Author Lehmann, Sylvain
-
2012 | Review
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A. H.& Kapaki, E. et al. (2012)
Biomarkers in Medicine, 6(4) pp. 419-430.
Future Medicine Ltd. DOI: https://doi.org/10.2217/BMM.12.46
Details DOI PMID PMC WoS
-
2015 | Journal Article |
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 216. DOI: https://doi.org/10.3389/fneur.2015.00216
Details DOI PMID PMC WoS
-
2016 | Journal Article
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al. (2016)
Journal of Alzheimer's Disease, 52(1) pp. 51-64. DOI: https://doi.org/10.3233/jad-150883
Details DOI
-
2018 | Journal Article |
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P. & Lleó, A. et al. (2018)
Alzheimer's Research & Therapy, 10(1). DOI: https://doi.org/10.1186/s13195-018-0359-x
Details DOI
-
2018 | Journal Article |
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al. (2018)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10 pp. 461-470. DOI: https://doi.org/10.1016/j.dadm.2018.06.005
Details DOI PMID PMC
-
2020 | Journal Article
International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease
Delaby, C.; Teunissen, C. E; Alcolea, D.; Amar, E. B.; Beaume, A.; Bedel, A. & Bigot‐Corbel, E. et al. (2020)
Alzheimer's & Dementia, 16(S5). DOI: https://doi.org/10.1002/alz.047209
Details DOI
-
2020 | Journal Article
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study
Saddiki, H.; Fayosse, A.; Cognat, E.; Sabia, S.; Engelborghs, S.; Wallon, D. & Alexopoulos, P. et al. (2020)
PLoS Medicine, 17(8) pp. e1003289. DOI: https://doi.org/10.1371/journal.pmed.1003289
Details DOI
-
2021 | Journal Article
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
Delaby, C.; Teunissen, C. E.; Blennow, K.; Alcolea, D.; Arisi, I.; Amar, E. B. & Beaume, A. et al. (2021)
Alzheimer's & Dementia,. DOI: https://doi.org/10.1002/alz.12545
Details DOI